Skip to content

Immunovant

US · IMVT #1790 by market cap Listed 2017
31.77 -0.75 -2.31%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Cuts Target Price to $49
    Market Newswire · 2026/11/13
  • Rating change
    J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/8/10
  • Rating change
    BofA Securities Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/10/12
  • Rating change
    LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $53
    Market Newswire · 2026/9/26
  • Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/11/10
  • BofA Securities Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/11/10
  • Rating change
    J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/5/27
  • Rating change
    LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53
    Market Newswire · 2026/7/9
  • Rating change
    Guggenheim Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $62
    Market Newswire · 2026/5/26
  • Rating change
    A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $41 to $66
    Market Newswire · 2026/8/8
  • Rating change
    Truist Financial Maintains Immunovant(IMVT.US) With Hold Rating
    Market Newswire · 2026/9/24
  • H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/11/11
  • Rating change
    Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $57
    Market Newswire · 2026/8/13
  • Rating change
    Bernstein Initiates Immunovant(IMVT.US) With Hold Rating, Announces Target Price $37
    Market Newswire · 2026/9/26
  • Rating change
    H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $41
    Market Newswire · 2026/8/7
  • Rating change
    J.P. Morgan Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/8/4
  • Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/11/10
  • Rating change
    Piper Sandler Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $66
    Market Newswire · 2026/9/21
  • Rating change
    Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61
    Market Newswire · 2026/6/30
  • Rating change
    J.P. Morgan Sticks to Their Buy Rating for Immunovant (IMVT)
    TipRanks · 2026/8/10
  • Rating change
    H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/26
  • Rating change
    A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $40 to $45
    Market Newswire · 2026/5/22
  • Rating change
    LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/5/23
  • Rating change
    H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/9/24
  • Rating change
    Stifel Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $49
    Market Newswire · 2026/5/25

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Immunovant discussion 0 comments

Add a comment